Imunon, Inc.
IMNN
Positions held
Your positionsIMNN isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $6.00M | Enterprise value | $9.24M | Trailing P/E | — | Forward P/E | -0.60 |
| PEG | 5.03 | Price / book | 2.58 | Beta | 2.01 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -4.3% | ROA | -78.0% | Debt / equity | 1.87 |
| Current ratio | 1.82 | Free cash flow | -$9.53M | Analyst recommendation | strong_buy | Mean target | $17.00 |
| 52w high | $5.39 | 52w low | $1.03 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | — | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — | — |
| Net income | — | -$4.2M | -$4.2M | -$3.4M | -$2.7M | -$4.1M |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | -$4.3M | -$4.3M | -$3.5M | -$2.8M | -$4.1M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.5M | — |
| Op margin | — | — | — | -4984.3% | — |
| Net income | -$14.5M | -$18.6M | -$19.5M | -$35.9M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$14.7M | -$19.1M | -$21.0M | -$24.9M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · IMUNON to Participate in Upcoming Investor Conferences
2026-10-01 · IMNN: R&D Day Highlights IMNN-001 Data in Frontline Ovarian Cancer
2026-09-29 · IMUNON Converts $1.2 Million of Debt-to-Equity
2026-09-09 · IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress
2026-08-26 · IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
2026-08-19 · IMNN: Strong Enrollment Momentum Continuing for Phase 3 OVATION 3 Trial
2026-08-12 · Imunon (IMNN) Q2 2026 Earnings Call Transcript
2026-08-11 · Imunon, Inc. Q2 2026 Earnings Call Summary
2026-08-11 · IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update
Price (daily)
Full chart · RSI · MACD · patterns